What You Should Know
- The Funding: New York-based Courier Health has closed a $50 million Series B funding round led by Oak HC/FT, with participation from existing investors Norwest and Work-Bench.
- The Clinical Disconnect: Despite massive clinical innovation in life sciences, getting patients prescribed to actually start and stay on their medications is a logistical nightmare. According to the 2026 State of Patient-Centricity report, nearly 60% of biopharma companies consider their data fragmented or inactionable.
- The Tech Solution: Courier Health solves this by connecting siloed data systems and deploying agentic AI to manage the end-to-end patient journey. The platform handles education, patient enrollment, benefits and prior authorization, therapy initiation, and long-term adherence.
Bridging the AI Maturity Gap
To understand the enterprise demand for Courier Health—which saw its customer base grow by over 400% in 2025—you have to look at the structural data deficits within life sciences organizations.
According to the 2026 State of Patient-Centricity report, nearly 60% of biopharma companies admit their data is fragmented and inactionable. Worse, less than 10% have the internal data maturity required to deploy artificial intelligence meaningfully.
Courier Health acts as the connective tissue. The platform deeply integrates disparate data sources and deploys context-rich “agentic AI” to execute key tasks. Instead of human staff manually tracking down benefits information or trying to figure out why a patient abandoned a prescription at the pharmacy counter, Courier Health’s AI automatically surfaces insights, identifies at-risk patients, and orchestrates the necessary interventions to keep the therapy on track.
“Our vision is to re-write the patient experience in healthcare, starting with simplifying and coordinating complex patient journeys for those who depend on innovative medicines,” said Danny Sigurdson, Founder and CEO of Courier Health.
Rapid Market Expansion
To keep pace with this demand, the company more than doubled its headcount. The new capital will be used to further scale the team and advance agentic AI capabilities that automate key tasks within the patient service workflow.
